umbilical cord-derived mesenchymal stem cells (Qingdao Allcare Biomedical Development)

N/A

Report date: 2025/03/20 09:19:45

Base Information

Drug Nameumbilical cord-derived mesenchymal stem cells (Qingdao Allcare Biomedical Development)
Drug Alias Namehuman umbilical cord mesenchymal stem cells (Qingdao Allcare Biomedical Development)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQingdao Aoke Biological Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQingdao Aoke Biological Development Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A